肾缺血再灌注损伤后单次给予FGF2可减轻损伤后间质纤维化
研究在大鼠单侧肾缺血再灌注加对侧肾切除模型中,比较假手术组、I/R组、I/R-FGF2组和FGF2-3D组,观察2个月。再灌注后1小时或3天单次给予外源性FGF2,两治疗组肾间质纤维化严重程度均较I/R组显著减轻,机制涉及减少HMGB1介导的炎症反应、抑制TGF-β1/Smads信号诱导的上皮-间质转化及维持管周毛细血管结构。
要点
- 再灌注后1小时或3天单次给予FGF2,均减轻大鼠肾间质纤维化。
- 保护作用与减少HMGB1介导的炎症反应相关。
- 保护作用与抑制TGF-β1/Smads诱导的上皮-间质转化及维持管周毛细血管结构相关。
核心结论
- 再灌注后1小时或3天单次给予外源性FGF2可抑制大鼠肾脏纤维化形成,从而阻断AKI向CKD转化。
- 作者认为研究为FGF信号在AKI向CKD进展中的作用提供了新见解,并强调了基于FGF的治疗对该疾病的潜力。
研究设计与样本
- 采用单侧肾缺血再灌注加对侧肾切除的体内模型模拟AKI及后续CKD。
- 大鼠随机分为四组:假手术组、I/R组、I/R-FGF2组和FGF2-3D组,监测长达2个月。
- 检测血清肌酐、炎症反应和肾脏组织病理学改变,并检查波形蛋白、α-SMA、CD31和CD34的表达。
主要发现
- I/R损伤后2个月,I/R-FGF2组和FGF2-3D组的肾间质纤维化严重程度均较I/R组显著减轻。
- FGF2的保护作用与减少高迁移率族蛋白B1(HMGB1)介导的炎症反应相关。
- 保护作用还与抑制转化生长因子β1(TGF-β1)/Smads信号诱导的上皮-间质转化及维持管周毛细血管结构相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite lack of clinical therapy in acute kidney injury (AKI) or its progression to chronic kidney disease (CKD), administration of growth factors shows great potential in the treatment of renal repair and further fibrosis. At an early phase of AKI, administration of exogenous fibroblast growth factor 2 (FGF2) protects against renal injury by inhibition of mitochondrial damage and inflammatory response. Here, we investigated whether this treatment attenuates the long-term renal interstitial fibrosis induced by ischemia-reperfusion (I/R) injury. METHODS: Unilateral renal I/R with contralateral nephrectomy was utilized as an in vivo model for AKI and subsequent CKD. Rats were randomly divided into four groups: Sham-operation group, I/R group, I/R-FGF2 group and FGF2-3D group. These groups were monitored for up to 2 months. Serum creatinine, inflammatory response and renal histopathology changes were detected to evaluate the role of FGF2 in AKI and followed renal interstitial fibrosis. Moreover, the expression of vimentin, α-SMA, CD31 and CD34 were examined. RESULTS: Two months after I/R injury, the severity of renal interstitial fibrosis was significantly attenuated in both of I/R-FGF2 group and FGF2-3D group, compared with the I/R group. The protective effects of FGF2 administration were associated with the reduction of high-mobility group box 1 (HMGB1)-mediated inflammatory response, the inhibition of transforming growth factor beta (TGF-β1)/Smads signaling-induced epithelial-mesenchymal transition and the maintenance of peritubular capillary structure. CONCLUSIONS: A single dose of exogenous FGF2 administration 1 h or 3 days after reperfusion inhibited renal fibrogenesis and thus blocked the transition of AKI to CKD. Our findings provided novel insight into the role of FGF signaling in AKI-to-CKD progression and underscored the potential of FGF-based therapy for this devastating disease.
引用
- Tan X, Tao Q, Yin S, et al. A single administration of FGF2 after renal ischemia-reperfusion injury alleviates post-injury interstitial fibrosis. Nephrol Dial Transplant. 2023. PMID: 37243325. doi:10.1093/ndt/gfad114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。